Multi-drug Resistant Organisms (MDROs) have important infection control implications, with the severity and extent of disease varying by patient population. Patients with an MDRO infection will have limited available antimicrobial therapy, and an increased length of stay and cost. Studies also indicate that patients with an MDRO infection have an increased rate of mortality.